[go: up one dir, main page]

MXPA03003714A - Antagonistas del receptor crf y metodos relacionados con los mismos. - Google Patents

Antagonistas del receptor crf y metodos relacionados con los mismos.

Info

Publication number
MXPA03003714A
MXPA03003714A MXPA03003714A MXPA03003714A MXPA03003714A MX PA03003714 A MXPA03003714 A MX PA03003714A MX PA03003714 A MXPA03003714 A MX PA03003714A MX PA03003714 A MXPA03003714 A MX PA03003714A MX PA03003714 A MXPA03003714 A MX PA03003714A
Authority
MX
Mexico
Prior art keywords
receptor antagonists
crf receptor
methods relating
crf
treatment
Prior art date
Application number
MXPA03003714A
Other languages
English (en)
Inventor
Charles Q Huang
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of MXPA03003714A publication Critical patent/MXPA03003714A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describen antagonistas del receptor de CRF, los cuales tienen utilidad en el tratamiento de una variedad de padecimientos, incluyendo el tratamiento de padecimientos que manifiestan hipersecrecion de CRF, tal como ataques, en animales de sangre caliente.
MXPA03003714A 2000-11-03 2001-11-02 Antagonistas del receptor crf y metodos relacionados con los mismos. MXPA03003714A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24582100P 2000-11-03 2000-11-03
PCT/US2001/047919 WO2002040480A2 (en) 2000-11-03 2001-11-02 Crf receptor antagonists and methods relating thereto

Publications (1)

Publication Number Publication Date
MXPA03003714A true MXPA03003714A (es) 2004-05-04

Family

ID=22928212

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003714A MXPA03003714A (es) 2000-11-03 2001-11-02 Antagonistas del receptor crf y metodos relacionados con los mismos.

Country Status (11)

Country Link
US (2) US6747034B2 (es)
EP (1) EP1341793B1 (es)
JP (1) JP2004529075A (es)
KR (1) KR20030060927A (es)
AU (2) AU2002239589B2 (es)
CA (1) CA2427656A1 (es)
DE (1) DE60126134T2 (es)
ES (1) ES2279835T3 (es)
MX (1) MXPA03003714A (es)
NO (1) NO20031997D0 (es)
WO (1) WO2002040480A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273871B2 (en) * 2001-07-17 2007-09-25 Sb Pharmco Puerto Rico Inc. Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists
AU2004205642C1 (en) 2003-01-14 2012-01-12 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
PL1680426T3 (pl) * 2003-06-10 2008-02-29 Hoffmann La Roche Pochodne 1,3,4-triazafenalenu i 1,3,4,6-tetraazafenalenu
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
WO2005007658A2 (en) 2003-07-14 2005-01-27 Arena Pharmaceuticals, Inc. Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
WO2005063749A1 (en) * 2003-12-22 2005-07-14 Sb Pharmco Puerto Rico Inc Crf receptor antagonists and methods relating thereto
US7869958B2 (en) * 2004-08-09 2011-01-11 Research Development Foundation Structure-based modulators of B1 G-protein coupled receptors
US20060178307A1 (en) * 2005-01-26 2006-08-10 The Regents Of The University Of California Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor
SG188548A1 (en) 2010-09-22 2013-04-30 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
NZ734220A (en) 2015-01-06 2022-01-28 Arena Pharm Inc Methods of treating conditions related to the s1p1 receptor
KR102603199B1 (ko) 2015-06-22 2023-11-16 아레나 파마슈티칼스, 인크. Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염
KR20190116416A (ko) 2017-02-16 2019-10-14 아레나 파마슈티칼스, 인크. 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법
BR112020024762A2 (pt) 2018-06-06 2021-03-23 Arena Pharmaceuticals, Inc. métodos de tratamento de condições relacionadas ao receptor s1p1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2180338T3 (es) 1998-11-12 2003-02-01 Neurocrine Biosciences Inc Antagonistas del receptor de crf y metodos relacionados.
JP2002529469A (ja) * 1998-11-12 2002-09-10 ニューロクライン バイオサイエンシーズ， インコーポレイテッド Ｃｒｆレセプターアンタゴニストおよびそれに関する方法

Also Published As

Publication number Publication date
CA2427656A1 (en) 2002-05-23
US6747034B2 (en) 2004-06-08
JP2004529075A (ja) 2004-09-24
DE60126134T2 (de) 2007-10-18
US20020151557A1 (en) 2002-10-17
NO20031997L (no) 2003-05-02
AU3958902A (en) 2002-05-27
AU2002239589B2 (en) 2005-04-21
NO20031997D0 (no) 2003-05-02
US20040266799A1 (en) 2004-12-30
DE60126134D1 (de) 2007-03-08
WO2002040480A3 (en) 2003-05-15
ES2279835T3 (es) 2007-09-01
WO2002040480A2 (en) 2002-05-23
EP1341793A2 (en) 2003-09-10
KR20030060927A (ko) 2003-07-16
EP1341793B1 (en) 2007-01-17

Similar Documents

Publication Publication Date Title
WO1998035967A3 (en) Biazacyclic crf antagonists
SI1627050T1 (sl) Varianta humicola grisea cbh1.1
MY130489A (en) Substituted aryl 1, 4-pyrazine derivatives
PL375599A1 (en) Multi-purpose polymers, methods and compositions
MXPA03003714A (es) Antagonistas del receptor crf y metodos relacionados con los mismos.
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
TW200519110A (en) Substituted tetrahydro-1H-pyrazolo [3, 4-c] pyridines, compositions comprising them, and use
HK1038925A1 (en) Crf receptor antagonists and methods relating thereto crf
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
ZA200407794B (en) Novel biomaterials, their preparation and use.
MXPA03006991A (es) Derivados de piperidina como antagonistas de neurocinina 1.
AU2002359495A8 (en) Anti-tnf antibodies, compositions, methods and uses
IL145018A0 (en) Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
ZA200105737B (en) N-Triazolyl-methyl-piperazine derivates as neurokinin- receptor antagonists.
EP1474535A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF AIDS AND HIV RELATED DISORDERS USING MOLECULES 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324 , 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045.
NO20011287L (no) Vedovn med dreieledeplate, samt fremgangsmåte
CA98409S (en) Electric toothbrush
CA97550S (en) Golf bag
HK1079708A1 (zh) 可用作毒蕈碱性受體拮抗劑的3，6-二取代氮雜二環[3．1．10]己烷衍生物
AU2002360531A8 (en) Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201
IL169318A0 (en) Pyrimidines, methods for the production thereof, and use thereof
AU2001263329A1 (en) Crf receptor antagonists and methods relating thereto
HK1049485A1 (en) DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses.
MXPA03009214A (es) METODO E INSTALACIoN PARA LA FABRICACIoN DE FELPUDOS Y USO ASOCIADO.
ZA200303236B (en) Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same.

Legal Events

Date Code Title Description
FG Grant or registration